CRRL269
/ Mayo Clinic
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 02, 2019
CRRL269: A Novel Particulate Guanylyl Cyclase A Receptor Peptide Activator For Acute Kidney Injury.
(PubMed, Circ Res)
- "Our study supports developing CRRL269 as a novel renocardiac protective agent for AKI treatment."
Biomarker • Journal
1 to 1
Of
1
Go to page
1